In Brief
Refine Search
Pharmaceutical
UK-based immunotherapy firm Centauri Therapeutics has secured a £1 million ($1.25 million) grant from PACE (Pathways to Antimicrobial Clinical Efficacy) to further develop its Alphamer technology. 25 November 2024
Biotechnology
Germany’s Evotec says it has taken notice of the statement made by Halozyme Therapeutics on November 22, stating that it has withdrawn its non-binding proposal to acquire Evotec for 11.00 euros per share in cash. 23 November 2024
Biotechnology
Colorado, USA-based OncoVerity announced the closing of a series A extension led by existing investors, argenX and RefinedScience. The value was not disclosed, but this extension follows a $30 million Series A fundraiser in March 2023. 22 November 2024
Biotechnology
Sweden-based BioArctic saw its fall 7.5% to 139.90 kronor on Friday, after its announced that its partner, Japan’s Eisa, has updated its revenue outlook for the Alzheimer’s treatment Leqembi (lecanemab) for the 2024 fiscal year (FY), which runs from April 2024 through March 2025. 11 November 2024
Biotechnology
Danish biotech Gubra announces that Germany’s Boehringer Ingelheim has decided to discontinue the development of the long-acting neuropeptide Y receptor type 2 (NPY2R) agonist BI 1820237 in obesity. 4 November 2024
Biotechnology
Japanese drugmaker Eisai has completed the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for lecanemab-irmb (US brand name Leqembi) subcutaneous autoinjector for weekly maintenance dosing after it was granted Fast Track designation by the FDA. 1 November 2024
Pharmaceutical
GSK has announced its largest US manufacturing investment to date, dedicated to producing medicines and vaccines. 25 October 2024
Pharmaceutical
Following a re-examination, the European Medicines Agency’s human health committee, CHMP confirmed its initial recommendation to refuse the granting of a conditional marketing authorization for Masitinib AB Science’s masitinib. 18 October 2024
Pharmaceutical
University Medical Center Groningen (UMCG) and SHINE Europe have secured a 10.5 million euro ($11 million) grant to advance European production of terbium isotopes for cancer treatments. 17 October 2024
Pharmaceutical
Danish dermatology focused LEO Pharma has announced the launch of Anzupgo (delgocitinib) cream in Germany for the treatment of adult patients with moderate to severe chronic hand eczema (CHE), for whom topical corticosteroids are inadequate or inappropriate. 15 October 2024
Pharmaceutical
French pharma major Sanofi revealed it has entered into negotiations with private equity firm Clayton Dubilier & Rice (CD&R) for the potential sale of a 50% controlling stake in Opella, its consumer healthcare business. 14 October 2024
Pharmaceutical
The UK’s new 2024 voluntary scheme for branded medicines pricing, access, and growth (VPAG) came into force at the beginning of January this year. 4 October 2024
Biotechnology
Sirnaomics, a firm specializing in RNAi therapeutics, has entered into a subscription agreement with biotech specialist Poon Hung Fai. 4 October 2024
Biotechnology
GigaGen has been awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the US Department of Health and Human Services (HHS). 4 October 2024
Biotechnology
Oxford, UK-based Enara Bio today announces the closing of a $32.5 million Series B financing supported by a strong syndicate of new and existing biotech investors. 3 October 2024
Pharmaceutical
French drugmaker Mitem Pharmavhas the worldwide acquisition of Desferal (deferoxamine), a major MITM in hematology, from Swiss giant Novartis. 25 September 2024
article
The European Medicines Agency’s (EMA) Committee for Human Medicinal Products (CHMP) has elected Bruno Sepodes as its new chair. 19 September 2024
Pharmaceutical
The Austrian Academy of Sciences (OeAW) is further expanding its focus on life sciences by opening an institute for biomedical artificial intelligence (AI) based on a 150 million euros ($166.8 million) funding from the German non-profit Boehringer Ingelheim Foundation (BIS). 18 September 2024
Biotechnology
Zenas BioPharma announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering price of $17.00 per share. 13 September 2024
Biosimilars
Similis Bio, the JSR Life Sciences business unit focused on biosimilar development, has announced plans to enter into a partnership with Novel351k. 16 February 2023
Biotechnology
Swedish biotech Aqilion has announced a deal with Germany’s Merck KGaA. 16 February 2023
Biotechnology
Privately-held Direct Biologics has named Amy Lightner its chief medical officer. 16 February 2023
Biotechnology
US biotech Capricor Therapeutics has entered into a partnership with mid-sized Japanese drugmaker Nippon Shinyaku, for the exclusive commercialization and distribution in Japan of Capricor’s lead asset, CAP-1002, for the treatment of Duchenne muscular dystrophy (DMD), a rare neuromuscular disease with limited treatment options. 16 February 2023
Biotechnology
US biotech Seagen was trading 12% higher early in Thursday’s trading after its latest financial results beat estimates. 16 February 2023
Biotechnology
French biotech firms Erytech Pharma and Pherecydes Pharma today announced they intend to merge their operations and relocate all teams to Erytech’s premises in Lyon, France, where they would benefit from presence in a major European hub for infectious diseases. 16 February 2023
Biotechnology
Dutch rare disease specialist Pharming has suffered a setback in the European approval process for its leniolisib, a treatment for activated phosphoinositide 3-kinase delta syndrome (APDS), a rare primary immunodeficiency. 16 February 2023
Biotechnology
Japanese drugmaker Shionogi recently won approval for Xocova (ensitrelvir) for SARS-CoV-2 infection in Japan. 16 February 2023
Pharmaceutical
Spanish producer of blood plasma-based products Grifols has joined the ranks of pharma and biotech companies cutting their budgets and workforces, in a move that was welcomed by investors, with the firm’s shares rising 9% Wednesday and a further 8.6% to 14.76 euros this morning. 16 February 2023
Biotechnology
Privately-held Italian biotech Enthera Pharmaceuticals today announces the appointment of Filippo Canducci as chief medical officer. 16 February 2023
Biotechnology
US biotech Arrowhead Pharmaceuticals yesterday revealed receiving a written notice from US healthcare giant Johnson & Johnson’s Janssen unit that it has terminated its rights to JNJ-75220795, now called ARO-PNPLA3, under the October 2018 research collaboration and option agreement, as part of J&J’s strategic R&D portfolio review. 16 February 2023
Generics
Indian drugmaker Glenmark Pharmaceuticals (BSE: 532296) and US pharma giant Merck & Co (NYSE: MRK) are facing an antitrust lawsuit over allegations that the duo illegally settled a patent dispute in order to delay the launch of generic versions of the blockbuster cholesterol reducer Zetia (ezetimibe). 16 February 2023
Pharmaceutical
Italian central nervous system (CNS) specialist Newron Pharmaceuticals saw its shares leap more than 17% to 5.12 Swiss francs this morning, after it announced what it called ‘very exciting’ results for its antipsychotic candidate evenamide. 16 February 2023
Pharmaceutical
Denmark’s Bavarian Nordic, which has won a number of significant contracts for its smallpox vaccine Imvanex that has also shown efficacy against monkeypox, an infectious disease that has been spreading strongly, is now taking advantage of its windfall to expand its travel vaccines portfolio. 15 February 2023
Biotechnology
Sesen Bio and Carisma Therapeutics have further changed their previously amended merger agreement following investor pushback. 15 February 2023
Biotechnology
February 15, 2023
US biotech major Biogen today reported financials for 2022, showing that fourth quarter revenues were $2,544 million, a decline of 7% but beating consensus forecasts of $2.45 billion. 15 February 2023
Biotechnology
Hematologic diseases specialist Disc Medicine has announced a $62.5 million financing. 15 February 2023
Pharmaceutical
The Secretary of the US Department of Health and Human Services (HHS) has selected three new models for testing by the Centers for Medicare & Medicaid Services’ (CMS) Innovation Center to help lower the high cost of medicines in the USA. 15 February 2023
Generics
Indian generics major Zydus Lifesciences has received tentative approval from the US Food and Drug Administration (FDA) to market canagliflozin tablets, 100mg and 300mg. 15 February 2023
Biotechnology
With its recently granted expanded approval by the US Food and Drug Administration (FDA) for Gilead Sciences’ Trodelvy (sacituzumab govitecan-hziy) - for patients with HR-positive/HER2-negative metastatic breast cancer who have received hormonal therapy and at least two additional therapies – the drug is expected to become a standard of care for these breast cancer patients, who have had limited treatment options. 15 February 2023
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze